New 52 Week Low Today

Galapagos NV GLPG-NL:Euronext Amsterdam

RT Quote | Exchange | EUR
Last | 11:24 AM CEST
25.94quote price arrow down-0.20 (-0.77%)
Volume
10,681
52 week range
25.84 - 41.92
Loading...
  • Open26.08
  • Day High26.14
  • Day Low25.84
  • Prev Close26.14
  • 52 Week High41.92
  • 52 Week High Date05/24/23
  • 52 Week Low25.84
  • 52 Week Low Date05/23/24

Key Stats

  • Market Cap1,965.48M
  • Shares Out65.9M
  • 10 Day Average Volume111,124.11
  • Dividend-
  • Dividend Yield-
  • Beta0.08
  • YTD % Change-29.93

KEY STATS

  • Open26.08
  • Day High26.14
  • Day Low25.84
  • Prev Close26.14
  • 52 Week High41.92
  • 52 Week High Date05/24/23
  • 52 Week Low25.84
  • 52 Week Low Date05/23/24
  • Market Cap1,965.48M
  • Shares Out65.9M
  • 10 Day Average Volume111,124.11
  • Dividend-
  • Dividend Yield-
  • Beta0.08
  • YTD % Change-29.93

RATIOS/PROFITABILITY

  • EPS (TTM)0.47
  • P/E (TTM)55.67
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galapagos NV

 

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It...
Paulus Stoffels
Chairman of the Board, Chief Executive Officer
Thad Huston
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Member of the Management Board
Valeria Cnossen
Executive Vice President, General Counsel, Member of the Management Board
Address
Generaal De Wittelaan L11 A3
Malines (mechelen)
2800
Belgium